1. Bliss GVS Pharma
stock logo

Bliss GVS Pharma Share Price

BLISSGVS

₹121.20+₹9.18 (8.19%) TodayLast updated on 24 Jul, 2024 | 15:40 IST
₹112.02₹123.95
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹1,176 Crs

Open

₹112.02

Close

₹112.02

Circuit range

₹134.42 - ₹89.61

Day range

₹112.02 - ₹123.95

Year range

₹77.35 - ₹149.60

Volume

28,87,951

Avg. traded

₹120.37

Revenue (12m)

₹770 Crs

Bliss GVS PharmaBliss GVS Pharma Limited is engaged in developing, manufacturing, and marketing pharmaceutical formulations. The Company’s product categories include pharma products, other healthcare products, and therapeutic index. Its pharma products include pharma products include capsules, creams, gels, ointments, dry powder for injection, effervescent tablets, eye/ear drops, nasal solution, lotions, lozenges, oral solids, and others. The Company’s other healthcare products include balm, nasal inhaler, solution, soap, roll on, shampoo, powder, spray, and petroleum jelly. Its brands include ANOMEX, ANOMEX DS, CONLAX 5/10, G - ALFENAC 100, GACET 80/125/170/250/500/1G, GMETH - 50/100, GSUNATE - 50/100/200, GVCAM - 7.5/15, GV-SOFT 1/2/3/4 G, LOFNAC - 12.5/25/50/100, MEFINOL, MELANEZ, MENINA - 25/100, TYRIDOL, VIGOTAMIN, COMIT 50, BG - CLIND, VAGID CL, ECOZOLE, GVGYL 500, GYNANFORT, GVGYL N, KLOVINAL, LONART, LONART FORTE, LONART Dispersible, FINMOL, GACET-500, NOVOGLIP-5, GVZOLE, and DOXYCYCLINE.

Bliss GVS Pharma Key indicators

arrow

52 week high

₹149.60

52 week low

₹77.35

P/E ratio

15.82

P/B ratio

1.22

ROE

5.31%

ROCE

7.36%

Dividend yield

0.45%

Debt/Equity ratio

0.07

EPS

4.84

Learn more

Investment checklist: (2/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

23.23%

Net profit margin

8.36%

ROE

5.31%

ROA

4.43%

ROCE

7.36%

Learn more

Bliss GVS Pharma Shareholder returns

arrow

1 day

+2.79%

1 week

-3.42%

1 month

+7.85%

3 months

-1.78%

1 year

+15.43%

3 years

+0.96%

5 years

-28.19%

Bliss GVS Pharma Share Price history

arrow
DayOpenCloseDay’s change
Tue, Jul 23 2024
₹109.40
₹112.02
+2.79%
Mon, Jul 22 2024
₹109.30
₹108.98
-1.18%
Fri, Jul 19 2024
₹111.29
₹110.28
-0.91%
Thu, Jul 18 2024
₹114.07
₹111.29
-2.44%
Tue, Jul 16 2024
₹117.44
₹114.07
-1.66%
Mon, Jul 15 2024
₹115.41
₹115.99
+0.50%
Fri, Jul 12 2024
₹116.99
₹115.41
-0.92%
Thu, Jul 11 2024
₹110.99
₹116.48
+5.47%

Shareholding info

arrow

Promoters (34.97%)

Mutual Funds (0%)

Retail and other (43.71%)

Foreign institutions-FII (14.74%)

Other domestic institutions (6.58%)

Retail and other

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹0.5/share

    Ex date 18 Jul 2024

    expand tab
  • Dividend • ₹0.5/share

    Ex date 12 Jul 2023

    expand tab
  • Dividend • ₹0.5/share

    Ex date 20 Jun 2022

    expand tab

Learn more

Frequently asked questions